What to do for an 8-year-old patient taking Vyvanse (lisdexamfetamine) 20mg for Attention Deficit Hyperactivity Disorder (ADHD) who has improved focus but is experiencing increased crying?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Emotional Lability (Increased Crying) in an 8-Year-Old on Vyvanse 20mg

This child is experiencing a recognized adverse effect of stimulant medication—emotional lability or dysphoria—which requires immediate dose adjustment or medication modification rather than continuation at the current regimen. 1

Understanding the Problem

The "crying a lot" represents emotional lability, a well-documented adverse effect of stimulant medications that can manifest as tearfulness, emotional overreaction, or dysphoric mood. 1 The American Academy of Child and Adolescent Psychiatry specifically notes that children treated with stimulants can become tearful and show emotional dysregulation, particularly as medication effects fluctuate throughout the day. 1

This is NOT a contraindication to stimulant therapy, but it IS an indication that the current medication approach needs modification. 1

Immediate Management Algorithm

Step 1: Determine Timing of Symptoms

  • If crying occurs primarily in late afternoon/evening (4-6 hours after dosing): This suggests "rebound" phenomenon as Vyvanse wears off, which is common with stimulants. 1
  • If crying occurs throughout the day: This suggests the medication itself is causing emotional dysregulation at the current dose or formulation. 1

Step 2: Initial Intervention Based on Timing

For rebound-related crying (late day symptoms):

  • Reduce the Vyvanse dose from 20mg to 10mg (the lowest available dose) to minimize the rebound effect. 2
  • Monitor for 1-2 weeks to assess if lower dose maintains therapeutic benefit for ADHD while reducing emotional side effects. 2
  • If 10mg provides inadequate ADHD control, consider splitting to twice-daily dosing or switching medication class entirely. 1

For all-day emotional lability:

  • Immediately reduce Vyvanse to 10mg as the first-line intervention. 2
  • The current 20mg dose is causing excessive emotional side effects that outweigh the therapeutic benefit. 1
  • Titration should have started at lower doses (5mg methylphenidate equivalent or 2.5mg amphetamine equivalent), and this child may have been started too high. 2

Step 3: If Dose Reduction Fails (After 1-2 Week Trial)

Switch to methylphenidate-based stimulant as the next step: 2

  • Methylphenidate is recommended as the traditional first-line stimulant with 70% response rates. 2
  • Start with long-acting methylphenidate formulation (e.g., Concerta 18mg or equivalent) to provide consistent coverage. 2
  • The American Academy of Child and Adolescent Psychiatry notes that amphetamine preparations (like Vyvanse) may cause more emotional side effects than methylphenidate in some children. 1
  • Titrate methylphenidate weekly in 5-10mg increments based on response and tolerability. 2

Step 4: If Methylphenidate Also Causes Emotional Problems

Consider non-stimulant medication: 2

  • Atomoxetine (Strattera) starting at 0.5 mg/kg/day, titrating to 1.2-1.4 mg/kg/day over 4-6 weeks. 2
  • Atomoxetine requires 4-6 weeks for full therapeutic effect but has lower risk of emotional side effects. 2
  • Extended-release guanfacine (Intuniv) 1-4mg daily is another option with effect size of ~0.7. 2

Critical Monitoring During Adjustment

At each visit (weekly during titration), systematically assess: 2

  • Core ADHD symptoms using standardized rating scales from both parents and teachers. 2
  • Emotional symptoms: frequency of crying, irritability, mood changes, social withdrawal. 1, 2
  • Other side effects: appetite, sleep, headaches, tics. 2
  • Blood pressure and pulse at every visit. 2

Common Pitfalls to Avoid

Do not continue current dose hoping symptoms will resolve: 1

  • Emotional dysregulation from stimulants typically does not improve with continued exposure at the same dose. 1
  • The American Academy of Child and Adolescent Psychiatry warns that clinicians should be cautious prescribing stimulants to patients with unstable mood. 1

Do not add another medication to treat the crying: 1

  • The crying is a direct adverse effect of the stimulant; address the root cause first. 1

Do not assume all stimulants will cause the same problem: 1, 2

  • Methylphenidate and amphetamine preparations have different side effect profiles, and switching classes is appropriate. 1, 2

Do not abandon ADHD treatment entirely: 1

  • Depression and emotional symptoms can be secondary to untreated ADHD, and some patients' mood improves when ADHD is adequately treated. 1
  • Systematic medication trials across different classes should be completed before concluding pharmacotherapy has failed. 2

Why Vyvanse May Be Problematic Here

Lisdexamfetamine (Vyvanse) is a prodrug that provides 12-14 hours of amphetamine effect through enzymatic conversion in the blood. 3, 4 While this long duration is advantageous for ADHD coverage, it also means prolonged exposure to amphetamine, which can increase risk of emotional side effects in vulnerable children. 1, 3 The 20mg dose may be excessive for this 8-year-old's tolerance, particularly as a starting dose. 2

Expected Timeline

  • Dose reduction effects: Should see improvement in crying within 3-7 days if dose-related. 1
  • Medication switch to methylphenidate: Allow 1-2 weeks at therapeutic dose to assess both efficacy and emotional tolerability. 2
  • Switch to atomoxetine: Requires 4-6 weeks for full therapeutic effect. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Selecting ADHD Medications for New Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.